The findings are based on up to 14 years of follow-up data from the Stockholm-Gotland region.
The Organisation of European Cancer Institutes gives green light for the next phase: an on-site review visit.
Vaccine accessibility, cost, and employer support may be just as important as knowledge of the disease.
The collaboration between SOLH and the Catalan network TECSAM creates new opportunities for innovation.
Seven research projects at Umeå University will receive a total of SEK 9 million in funding.
The main barriers to vaccination among high-risk groups are related to individual-level factors.
METAmeet 2026 brought leading nanophotonics researchers together for three days of exchange.
Researchers in Umeå conduct internationally recognized research on mosquito-borne diseases in humans.
Most cancer drugs target proteins. This strategy instead targets the virus's DNA.